Title:
PHARMACEUTICAL FORMULATIONS COMPRISING SODIUM PALMITOYL-L-PROLYL-L-PROLYL-GLYCYL-L-TYROSINATE AND METHODS FOR PREPARING THE SAME
Document Type and Number:
WIPO Patent Application WO/2021/040257
Kind Code:
A1
Abstract:
The present invention relates to a pharmaceutical formulation having excellent bioavailability and stability, comprising sodium palmitoyl-L-prolyl-L-prolyl-glycyl-L-tyrosinate (Compound I) as an active ingredient. The pharmaceutical formulation according to the present invention can be usefully used as a dosage form for treating inflammatory bowel disease and the like since Compound I, an active ingredient, is not decomposed in the stomach and released in the intestine.
Inventors:
KANG SANG UK (KR)
Application Number:
PCT/KR2020/010236
Publication Date:
March 04, 2021
Filing Date:
August 03, 2020
Export Citation:
Assignee:
BRIDGE BIOTHERAPEUTICS INC (KR)
International Classes:
A61K38/07; A61K9/20; A61P1/00; A61P29/00
Domestic Patent References:
| WO2010059922A1 | 2010-05-27 |
Foreign References:
| US20180208625A1 | 2018-07-26 | |||
| US20130115291A1 | 2013-05-09 | |||
| KR20070045194A | 2007-05-02 | |||
| KR20160040697A | 2016-04-14 | |||
| KR101504199B1 | 2015-03-19 | |||
| KR20090114320A | 2009-11-03 | |||
| KR102104507B1 | 2020-04-24 |
Other References:
See also references of EP 4017517A4
Attorney, Agent or Firm:
CHOI, Eun Sun (KR)
Download PDF: